Statistics for Catalyst Pharmaceuticals (id:5261 CPRX)
Valuation metrics
Market cap
2.53B
Enterprise value
2.12B
Trailing P/E (ttm)
17.94
Forward P/E
14.02
PEG ratio
14.02
Price/Sales (ttm)
5.48
Price/Book (mrq)
3.82
Enterprise Value/Revenue
4.60
Enterprise Value/EBITDA
10.03
Overview
Shares outstanding
119.27M
Float
103.02M
Shares short
6.09M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
775.89K
Average volume (90 days)
Price summary
52-Week low
13.12
52-Week high
24.27
52-Week change
19.42%
Beta
3.00
50-Day moving average
21.70
200-Day moving average
18.26
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
31.01%
Operating margin
39.56%
Operational effectiveness
Return on assets
18.35%
Return on equity
28.29%
Income statement
Revenue (ttm)
4.00
Revenue per share (ttm)
4.00
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
346.24M
EBITDA
211.94M
Net income to common (ttm)
142.80M
Diluted EPS (ttm)
1.18
Quarterly earnings growth (yoy)
25.33%
Balance sheet
Total cash (mrq)
442.33M
Total cash per share (mrq)
3.71
Total debt (mrq)
3.28M
Total Debt/Equity (mrq)
3.00
Current ratio (mrq)
511.40%
Book value per share (mrq)
5.54
Cash flow
Cash flow statement
224.58M
Levered free cash flow (LFCF)
150.67M